Daiichi Sankyo acquired 6.7 % of shares of Kitasato Daiichi Sankyo Vaccine owned by Kitasato, making it a fully owned subsidiary.
Daiichi Sanky news release, December 1, 2017
Daiichi Sankyo turns Kitasato vaccine joint venture into wholly owned subsidiary